These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 17260848)
1. Herpes zoster vaccine brings relief for the elderly. Morrow T Manag Care; 2006 Dec; 15(12):57-8. PubMed ID: 17260848 [No Abstract] [Full Text] [Related]
2. Zoster vaccine in older adults. Fried R J Am Geriatr Soc; 2010 Sep; 58(9):1799-800. PubMed ID: 20863342 [No Abstract] [Full Text] [Related]
3. Q: Who should receive the shingles vaccine? Singh A; Englund K Cleve Clin J Med; 2009 Jan; 76(1):45-8. PubMed ID: 19122110 [No Abstract] [Full Text] [Related]
4. [Study tests Varicella-Zoster vaccine for over 60-years-old persons. Protection from Herpes zoster and postherpetic neuralgia]. MMW Fortschr Med; 2006; Spec no.1():14-5. PubMed ID: 16872127 [No Abstract] [Full Text] [Related]
5. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Pellissier JM; Brisson M; Levin MJ Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938 [TBL] [Abstract][Full Text] [Related]
10. Varicella-zoster vaccine. Senanayake SN N Engl J Med; 2007 Jul; 357(1):89-90. PubMed ID: 17615639 [No Abstract] [Full Text] [Related]
11. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia. Betts RF J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866 [TBL] [Abstract][Full Text] [Related]
12. Rash redux. Why chicken pox strikes some adults a second time--as shingles--and how to avoid the repeat. Gupta S Time; 2008 Jul; 172(4):53. PubMed ID: 18831097 [No Abstract] [Full Text] [Related]
14. Prevention of herpes zoster and its painful and debilitating complications. Johnson R; McElhaney J; Pedalino B; Levin M Int J Infect Dis; 2007 Nov; 11 Suppl 2():S43-8. PubMed ID: 18162246 [TBL] [Abstract][Full Text] [Related]
15. Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderly. Opstelten W; van Essen GA; Hak E Vaccine; 2009 Jan; 27(2):192-6. PubMed ID: 18996427 [TBL] [Abstract][Full Text] [Related]
16. Experience with use of Zostavax(®) in patients with hematologic malignancy and hematopoietic cell transplant recipients. Naidus E; Damon L; Schwartz BS; Breed C; Liu C Am J Hematol; 2012 Jan; 87(1):123-5. PubMed ID: 22052650 [No Abstract] [Full Text] [Related]
18. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus]. Bonmarin I; Santa-Olalla P; Lévy-Bruhl D Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741 [TBL] [Abstract][Full Text] [Related]
19. Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 Nov; 60(44):1528. PubMed ID: 22071592 [TBL] [Abstract][Full Text] [Related]
20. [The clinical and epidemic characteristics of shingles (herpes zoster) and its prevention with vaccines]. Afonina NM; Mikheeva IV Ter Arkh; 2013; 85(11):130-3. PubMed ID: 24432613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]